Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 2021. Yet hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouters, Olivier J, Shadlen, Kenneth C, Salcher-Konrad, Maximilian, Pollard, Andrew J, Larson, Heidi J, Teerawattananon, Yot, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906643/
https://www.ncbi.nlm.nih.gov/pubmed/33587887
http://dx.doi.org/10.1016/S0140-6736(21)00306-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906643/
https://www.ncbi.nlm.nih.gov/pubmed/33587887
http://dx.doi.org/10.1016/S0140-6736(21)00306-8

Ejemplares similares